Ultragenyx Pharmaceutical (RARE)
(Real Time Quote from BATS)
$41.15 USD
-0.81 (-1.93%)
Updated May 8, 2024 01:14 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-1.63 | 0.83% |
Earnings Summary
For their last quarter, Ultragenyx Pharmaceutical (RARE) reported earnings of -$2.03 per share, missing the Zacks Consensus Estimate of -$1.72 per share. This reflects a negative earnings surprise of 18.02%. Look out for RARE's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.63 per share, reflecting a year-over-year increase of 27.56%.
Earnings History
Price & Consensus
Zacks News for RARE
Ultragenyx (RARE) Reports Q1 Earnings: What Key Metrics Have to Say
RARE: What are Zacks experts saying now?
Zacks Private Portfolio Services